Skip to content
Popular Searches
  • # Cancer
  • # Alzheimer's
  • # DNA
  • # FDA
  • # Diabetes
  • # Brain
  • linkedin
  • facebook
  • instagram
  • twitter
Home BiotechReality – Covering Industry, Business, and Academia

Explore the frontiers of Biotechnology, Pharma/Biopharma industry and Science with BiotechReality. We publish news, reports, views and articles.

  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
Trending

Trending

Moderna Reports Q1 2025 Results: Revenue Dips, Focus Shifts to Oncology Amid Expense Cuts

4 May 2025

Fever enhances the mitochondrial damage in immune cells

21 September 2024

Scientists map the human brain’s networks regulating the gene function

27 May 2024

Research: A new neural biomarker for OCD

14 July 2024

Research: Genes that encode immunity are altered in Alzheimer’s patients blood

12 February 2024

Thin Layer Chromatography (TLC) – Principle, Procedure, Diagram, and Applications

18 February 2024

MicroRNA (miRNA) – An Overview on Structure and its Working

18 October 2024

Amgen Reports Strong Q1 2025 Results Driven by Robust Volume Growth and Key Product Performance

5 May 2025

DNA preserved in an amber-like polymer

15 June 2024

Pleural mesothelioma (PM): New therapeutic approach to chemo-and radiotherapy sensitivity enhancement by Medical University of Vienna

12 October 2023

Research: CAR T cell longevity is controlled by the influence of a protein

11 April 2024

Combination of chemotherapy and dual-targeted treatments Phase III Breakwater Clinical trials supported for BRAF-mutated metastatic colorectal cancer FDA approval

26 January 2025

VENTANA MET

Roche’s VENTANA MET (SP44) RxDx Assay Receives FDA Approval as First Companion Diagnostic for MET-Positive NSCLC
Cancer Clinical Trials Healthcare & Pharmaceuticals News

Roche’s VENTANA MET (SP44) RxDx Assay Receives FDA Approval as First Companion Diagnostic for MET-Positive NSCLC

Athulya B S 15 May 2025

The VENTANA MET (SP44) RxDx Assay detects the MET, or c-Met, protein, which is overexpressed in about 25% of advanced NSQ-NSCLC patients with EGFR wild-type.

Areas Covered

  • Anti-obesity Drugs
  • Applications of Biotechnology
  • Artificial Intelligence
  • Astrobiology
  • Biochemistry
  • Bioengineering
  • Bioinformatics
  • Biostatistics
  • Biotechnology
  • Blog
  • Business
  • Cancer
  • Cell Biology
  • Clinical Investigation
  • Clinical Trials
  • Collection
  • Deep Learning
  • Diabetes
  • Diagnostic Tests
  • Disease Biology
  • Diseases
  • Drug Discovery
  • Drugs
  • Engineering
  • Epidemiology
  • Gene Therapy
  • General Biology
  • Genetics
  • Genomics
  • Healthcare & Pharmaceuticals
  • Immunology
  • Immunotherapy
  • Instrumentation
  • Laboratory Info
  • Life Sciences
  • Machine Learning
  • Medical Devices
  • Mental Health
  • Microbiology
  • Microscopy
  • Molecular Biology
  • Nanotechnology
  • Neuroscience
  • News
  • Pharmacology
  • Regenerative Medicine
  • Regulatory
  • Regulatory Approval
  • Research
  • Science
  • Science Communication
  • Staining
  • Technology
  • Therapies
  • Toxicology
  • Vaccines
  • Virology
  • Weight-loss Drugs
Market Analysis
Publish on BiotechReality

  • Roche Hiring Veeva Vault Business Systems Analysis Expert – Pune, India
  • Amgen Hiring Senior Data Engineer in Hyderabad, India – May 2025
  • Novo Nordisk Hiring Senior Regulatory Affairs Specialist in Seoul, South Korea – May 2025
  • Pfizer Hiring an IT Senior Associate in Chennai, India – April, 2025
  • IQVIA Hiring Clinical Data Specialist in Cochin, India – April 2025
SciRealityPress BiotechReality

A SciRealityPress Associate

Contents in the website is licensed under CC BY-NC 4.0

Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary. All trademarked names mentioned in the contents belongs to their respective owners. Stock exchange data providing by Stockdio

SciRealityPress © 2025
  • About
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Platform Status
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinuePrivacy policy